Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Acute myeloid leukemia 💬 18 genes, 37 drugs (DrugBank) and 71 diseases |
RARA [1] RARA 💬Acute myeloid leukemia
|
Isotretinoin Isotretinoin 💬Acute myeloid leukemia
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Adherens junction 💬 13 genes, 25 drugs (DrugBank) and 34 diseases |
EGFR [1] EGFR 💬Adherens junction
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Adherens junction
| Erlotinib | 094 [2] 94, 160 💬2. Adherens junction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Adherens junction 💬 13 genes, 25 drugs (DrugBank) and 34 diseases |
EGFR [1] EGFR 💬Adherens junction
|
Erlotinib Erlotinib 💬Adherens junction
| Erlotinib | 094 [2] 94, 160 💬2. Adherens junction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Adipocytokine signaling pathway 💬 18 genes, 40 drugs (DrugBank) and 108 diseases |
PPARA [1] PPARA 💬Adipocytokine signaling pathway
|
Bezafibrate Bezafibrate 💬Adipocytokine signaling pathway
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬4. Adipocytokine signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Adipocytokine signaling pathway 💬 18 genes, 40 drugs (DrugBank) and 108 diseases |
TNF [1] TNF 💬Adipocytokine signaling pathway
|
Adalimumab Adalimumab 💬Adipocytokine signaling pathway
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬5. Adipocytokine signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | African trypanosomiasis 💬 10 genes, 24 drugs (DrugBank) and 66 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬African trypanosomiasis
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬6. African trypanosomiasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | African trypanosomiasis 💬 10 genes, 24 drugs (DrugBank) and 66 diseases |
TNF [1] TNF 💬African trypanosomiasis
|
Adalimumab Adalimumab 💬African trypanosomiasis
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬7. African trypanosomiasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 58 drugs (DrugBank) and 100 diseases |
TNF [1] TNF 💬AGE-RAGE signaling pathway in diabetic complications
|
Adalimumab Adalimumab 💬AGE-RAGE signaling pathway in diabetic complications
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬8. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | Alcoholic liver disease 💬 43 genes, 56 drugs (DrugBank) and 98 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Alcoholic liver disease
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬9. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Alcoholic liver disease 💬 43 genes, 56 drugs (DrugBank) and 98 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Ixekizumab Ixekizumab 💬Alcoholic liver disease
| Ixekizumab | 036 [8] 36, 37, 46, 107, 160, 162, 269, 271 💬10. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11 | Alcoholic liver disease 💬 43 genes, 56 drugs (DrugBank) and 98 diseases |
IL17A [1] IL17A 💬Alcoholic liver disease
|
Secukinumab Secukinumab 💬Alcoholic liver disease
| Secukinumab | 013 [9] 13, 37, 40, 41, 46, 107, 160, 269, 271 💬11. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 12 | Alcoholic liver disease 💬 43 genes, 56 drugs (DrugBank) and 98 diseases |
PPARA [1] PPARA 💬Alcoholic liver disease
|
Bezafibrate Bezafibrate 💬Alcoholic liver disease
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬12. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13 | Alcoholic liver disease 💬 43 genes, 56 drugs (DrugBank) and 98 diseases |
TNF [1] TNF 💬Alcoholic liver disease
|
Adalimumab Adalimumab 💬Alcoholic liver disease
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬13. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 14 | Allograft rejection 💬 31 genes, 25 drugs (DrugBank) and 63 diseases |
CD80 [2] CD80, CD86 💬
|
Abatacept Abatacept 💬Allograft rejection
| Abatacept | 002 [28] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬14. Allograft rejection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15 | Allograft rejection 💬 31 genes, 25 drugs (DrugBank) and 63 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Allograft rejection
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬15. Allograft rejection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16 | Allograft rejection 💬 31 genes, 25 drugs (DrugBank) and 63 diseases |
TNF [1] TNF 💬Allograft rejection
|
Adalimumab Adalimumab 💬Allograft rejection
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬16. Allograft rejection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17 | Alzheimer disease 💬 59 genes, 136 drugs (DrugBank) and 139 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Alzheimer disease
|
Pimecrolimus Pimecrolimus 💬Alzheimer disease
| Pimecrolimus | 160 [1] 160 💬17. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 18 | Alzheimer disease 💬 59 genes, 136 drugs (DrugBank) and 139 diseases |
TNF [1] TNF 💬Alzheimer disease
|
Adalimumab Adalimumab 💬Alzheimer disease
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬18. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 19 | Amoebiasis 💬 20 genes, 32 drugs (DrugBank) and 77 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Amoebiasis
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬19. Amoebiasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20 | Amoebiasis 💬 20 genes, 32 drugs (DrugBank) and 77 diseases |
TNF [1] TNF 💬Amoebiasis
|
Adalimumab Adalimumab 💬Amoebiasis
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬20. Amoebiasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 21 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Amphetamine addiction
|
Pimecrolimus Pimecrolimus 💬Amphetamine addiction
| Pimecrolimus | 160 [1] 160 💬21. Amphetamine addiction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 22 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
HMGCR [1] HMGCR 💬AMPK signaling pathway
|
Atorvastatin calcium Atorvastatin calcium 💬AMPK signaling pathway
| Atorvastatin | 013 [21] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬22. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 23 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
HMGCR [1] HMGCR 💬AMPK signaling pathway
|
Atorvastatin Atorvastatin 💬AMPK signaling pathway
| Atorvastatin | 013 [21] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬22. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 24 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
HMGCR [1] HMGCR 💬AMPK signaling pathway
|
Lovastatin Lovastatin 💬AMPK signaling pathway
| Lovastatin | 006 [11] 6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬24. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 25 | AMPK signaling pathway 💬 16 genes, 58 drugs (DrugBank) and 100 diseases |
HMGCR [1] HMGCR 💬AMPK signaling pathway
|
Simvastatin Simvastatin 💬AMPK signaling pathway
| Simvastatin | 006 [22] 6 , 13, 15, 34, 46, 49, 51, 57, 66, 79, 86, 89, 94, 158, 160, 162, 195, 223, 265, 298, 299, 310 💬25. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 26 | Amyotrophic lateral sclerosis 💬 39 genes, 58 drugs (DrugBank) and 116 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Amyotrophic lateral sclerosis
|
Pimecrolimus Pimecrolimus 💬Amyotrophic lateral sclerosis
| Pimecrolimus | 160 [1] 160 💬26. Amyotrophic lateral sclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 27 | Amyotrophic lateral sclerosis 💬 39 genes, 58 drugs (DrugBank) and 116 diseases |
TNF [1] TNF 💬Amyotrophic lateral sclerosis
|
Adalimumab Adalimumab 💬Amyotrophic lateral sclerosis
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬27. Amyotrophic lateral sclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 28 | Antigen processing and presentation 💬 23 genes, 15 drugs (DrugBank) and 60 diseases |
TNF [1] TNF 💬Antigen processing and presentation
|
Adalimumab Adalimumab 💬Antigen processing and presentation
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬28. Antigen processing and presentation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 29 | Apoptosis 💬 18 genes, 32 drugs (DrugBank) and 68 diseases |
TNF [1] TNF 💬Apoptosis
|
Adalimumab Adalimumab 💬Apoptosis
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬29. Apoptosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 30 | Arachidonic acid metabolism 💬 5 genes, 29 drugs (DrugBank) and 46 diseases |
ALOX5 [1] ALOX5 💬Arachidonic acid metabolism
|
Zileuton Zileuton 💬Arachidonic acid metabolism
| Zileuton | 085 [3] 85, 160, 164 💬30. Arachidonic acid metabolism
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 31 | Asthma 💬 21 genes, 24 drugs (DrugBank) and 61 diseases |
TNF [1] TNF 💬Asthma
|
Adalimumab Adalimumab 💬Asthma
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬31. Asthma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 32 | Autoimmune thyroid disease 💬 42 genes, 16 drugs (DrugBank) and 38 diseases |
CD80 [2] CD80, CD86 💬
|
Abatacept Abatacept 💬Autoimmune thyroid disease
| Abatacept | 002 [28] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬32. Autoimmune thyroid disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 33 | Axon guidance 💬 22 genes, 26 drugs (DrugBank) and 73 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Axon guidance
|
Pimecrolimus Pimecrolimus 💬Axon guidance
| Pimecrolimus | 160 [1] 160 💬33. Axon guidance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 34 | B cell receptor signaling pathway 💬 19 genes, 38 drugs (DrugBank) and 68 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬B cell receptor signaling pathway
|
Pimecrolimus Pimecrolimus 💬B cell receptor signaling pathway
| Pimecrolimus | 160 [1] 160 💬34. B cell receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 35 | Bile secretion 💬 13 genes, 36 drugs (DrugBank) and 66 diseases |
HMGCR [1] HMGCR 💬Bile secretion
|
Atorvastatin calcium Atorvastatin calcium 💬Bile secretion
| Atorvastatin | 013 [21] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬35. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 36 | Bile secretion 💬 13 genes, 36 drugs (DrugBank) and 66 diseases |
HMGCR [1] HMGCR 💬Bile secretion
|
Atorvastatin Atorvastatin 💬Bile secretion
| Atorvastatin | 013 [21] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬35. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 37 | Bile secretion 💬 13 genes, 36 drugs (DrugBank) and 66 diseases |
HMGCR [1] HMGCR 💬Bile secretion
|
Lovastatin Lovastatin 💬Bile secretion
| Lovastatin | 006 [11] 6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬37. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 38 | Bile secretion 💬 13 genes, 36 drugs (DrugBank) and 66 diseases |
HMGCR [1] HMGCR 💬Bile secretion
|
Simvastatin Simvastatin 💬Bile secretion
| Simvastatin | 006 [22] 6 , 13, 15, 34, 46, 49, 51, 57, 66, 79, 86, 89, 94, 158, 160, 162, 195, 223, 265, 298, 299, 310 💬38. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 39 | Bladder cancer 💬 11 genes, 26 drugs (DrugBank) and 33 diseases |
EGFR [1] EGFR 💬Bladder cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Bladder cancer
| Erlotinib | 094 [2] 94, 160 💬39. Bladder cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 40 | Bladder cancer 💬 11 genes, 26 drugs (DrugBank) and 33 diseases |
EGFR [1] EGFR 💬Bladder cancer
|
Erlotinib Erlotinib 💬Bladder cancer
| Erlotinib | 094 [2] 94, 160 💬39. Bladder cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 41 | Breast cancer 💬 22 genes, 64 drugs (DrugBank) and 84 diseases |
EGFR [1] EGFR 💬Breast cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Breast cancer
| Erlotinib | 094 [2] 94, 160 💬41. Breast cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 42 | Breast cancer 💬 22 genes, 64 drugs (DrugBank) and 84 diseases |
EGFR [1] EGFR 💬Breast cancer
|
Erlotinib Erlotinib 💬Breast cancer
| Erlotinib | 094 [2] 94, 160 💬41. Breast cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 43 | C-type lectin receptor signaling pathway 💬 28 genes, 71 drugs (DrugBank) and 108 diseases |
IL12A [3] IL12A, IL12B, IL23A 💬
|
Ustekinumab Ustekinumab 💬C-type lectin receptor signaling pathway
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬43. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 44 | C-type lectin receptor signaling pathway 💬 28 genes, 71 drugs (DrugBank) and 108 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬C-type lectin receptor signaling pathway
|
Pimecrolimus Pimecrolimus 💬C-type lectin receptor signaling pathway
| Pimecrolimus | 160 [1] 160 💬44. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 45 | C-type lectin receptor signaling pathway 💬 28 genes, 71 drugs (DrugBank) and 108 diseases |
TNF [1] TNF 💬C-type lectin receptor signaling pathway
|
Adalimumab Adalimumab 💬C-type lectin receptor signaling pathway
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬45. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 46 | Cadherin signaling 💬 41 genes, 70 drugs (DrugBank) and 81 diseases |
EGFR [1] EGFR 💬Cadherin signaling
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Cadherin signaling
| Erlotinib | 094 [2] 94, 160 💬46. Cadherin signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 47 | Cadherin signaling 💬 41 genes, 70 drugs (DrugBank) and 81 diseases |
EGFR [1] EGFR 💬Cadherin signaling
|
Erlotinib Erlotinib 💬Cadherin signaling
| Erlotinib | 094 [2] 94, 160 💬46. Cadherin signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 48 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
EGFR [1] EGFR 💬Calcium signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Calcium signaling pathway
| Erlotinib | 094 [2] 94, 160 💬48. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 49 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
EGFR [1] EGFR 💬Calcium signaling pathway
|
Erlotinib Erlotinib 💬Calcium signaling pathway
| Erlotinib | 094 [2] 94, 160 💬48. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 50 | Calcium signaling pathway 💬 82 genes, 215 drugs (DrugBank) and 140 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Calcium signaling pathway
|
Pimecrolimus Pimecrolimus 💬Calcium signaling pathway
| Pimecrolimus | 160 [1] 160 💬50. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 51 | cAMP signaling pathway 💬 67 genes, 191 drugs (DrugBank) and 133 diseases |
PPARA [1] PPARA 💬cAMP signaling pathway
|
Bezafibrate Bezafibrate 💬cAMP signaling pathway
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬51. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 52 | Cell adhesion molecule (CAM) interaction 💬 41 genes, 32 drugs (DrugBank) and 40 diseases |
CD80 [2] CD80, CD86 💬
|
Abatacept Abatacept 💬Cell adhesion molecule (CAM) interaction
| Abatacept | 002 [28] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬52. Cell adhesion molecule (CAM) interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 53 | Cellular senescence 💬 35 genes, 48 drugs (DrugBank) and 97 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Cellular senescence
|
Pimecrolimus Pimecrolimus 💬Cellular senescence
| Pimecrolimus | 160 [1] 160 💬53. Cellular senescence
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 54 | Central carbon metabolism in cancer 💬 20 genes, 37 drugs (DrugBank) and 70 diseases |
EGFR [1] EGFR 💬Central carbon metabolism in cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Central carbon metabolism in cancer
| Erlotinib | 094 [2] 94, 160 💬54. Central carbon metabolism in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 55 | Central carbon metabolism in cancer 💬 20 genes, 37 drugs (DrugBank) and 70 diseases |
EGFR [1] EGFR 💬Central carbon metabolism in cancer
|
Erlotinib Erlotinib 💬Central carbon metabolism in cancer
| Erlotinib | 094 [2] 94, 160 💬54. Central carbon metabolism in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 56 | cGMP-PKG signaling pathway 💬 48 genes, 132 drugs (DrugBank) and 123 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬cGMP-PKG signaling pathway
|
Pimecrolimus Pimecrolimus 💬cGMP-PKG signaling pathway
| Pimecrolimus | 160 [1] 160 💬56. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 57 | Chagas disease 💬 32 genes, 59 drugs (DrugBank) and 88 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Chagas disease
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬57. Chagas disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 58 | Chagas disease 💬 32 genes, 59 drugs (DrugBank) and 88 diseases |
TNF [1] TNF 💬Chagas disease
|
Adalimumab Adalimumab 💬Chagas disease
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬58. Chagas disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 59 | Chemical carcinogenesis - reactive oxygen species 💬 24 genes, 37 drugs (DrugBank) and 53 diseases |
EGFR [1] EGFR 💬Chemical carcinogenesis - reactive oxygen species
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Chemical carcinogenesis - reactive oxygen species
| Erlotinib | 094 [2] 94, 160 💬59. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 60 | Chemical carcinogenesis - reactive oxygen species 💬 24 genes, 37 drugs (DrugBank) and 53 diseases |
EGFR [1] EGFR 💬Chemical carcinogenesis - reactive oxygen species
|
Erlotinib Erlotinib 💬Chemical carcinogenesis - reactive oxygen species
| Erlotinib | 094 [2] 94, 160 💬59. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 61 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
EGFR [1] EGFR 💬Chemical carcinogenesis - receptor activation
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Chemical carcinogenesis - receptor activation
| Erlotinib | 094 [2] 94, 160 💬61. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 62 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
EGFR [1] EGFR 💬Chemical carcinogenesis - receptor activation
|
Erlotinib Erlotinib 💬Chemical carcinogenesis - receptor activation
| Erlotinib | 094 [2] 94, 160 💬61. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 63 | Chemical carcinogenesis - receptor activation 💬 41 genes, 140 drugs (DrugBank) and 133 diseases |
PPARA [1] PPARA 💬Chemical carcinogenesis - receptor activation
|
Bezafibrate Bezafibrate 💬Chemical carcinogenesis - receptor activation
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬63. Chemical carcinogenesis - receptor activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 64 | Choline metabolism in cancer 💬 11 genes, 29 drugs (DrugBank) and 64 diseases |
EGFR [1] EGFR 💬Choline metabolism in cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Choline metabolism in cancer
| Erlotinib | 094 [2] 94, 160 💬64. Choline metabolism in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 65 | Choline metabolism in cancer 💬 11 genes, 29 drugs (DrugBank) and 64 diseases |
EGFR [1] EGFR 💬Choline metabolism in cancer
|
Erlotinib Erlotinib 💬Choline metabolism in cancer
| Erlotinib | 094 [2] 94, 160 💬64. Choline metabolism in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 66 | Colorectal cancer 💬 15 genes, 27 drugs (DrugBank) and 62 diseases |
EGFR [1] EGFR 💬Colorectal cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Colorectal cancer
| Erlotinib | 094 [2] 94, 160 💬66. Colorectal cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 67 | Colorectal cancer 💬 15 genes, 27 drugs (DrugBank) and 62 diseases |
EGFR [1] EGFR 💬Colorectal cancer
|
Erlotinib Erlotinib 💬Colorectal cancer
| Erlotinib | 094 [2] 94, 160 💬66. Colorectal cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 68 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
EGFR [1] EGFR 💬Coronavirus disease
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Coronavirus disease
| Erlotinib | 094 [2] 94, 160 💬68. Coronavirus disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 69 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
EGFR [1] EGFR 💬Coronavirus disease
|
Erlotinib Erlotinib 💬Coronavirus disease
| Erlotinib | 094 [2] 94, 160 💬68. Coronavirus disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 70 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Coronavirus disease
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬70. Coronavirus disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 71 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
TNF [1] TNF 💬Coronavirus disease
|
Adalimumab Adalimumab 💬Coronavirus disease
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬71. Coronavirus disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 72 | Coronavirus disease 💬 56 genes, 115 drugs (DrugBank) and 109 diseases |
TYK2 [1] TYK2 💬Coronavirus disease
|
Deucravacitinib Deucravacitinib 💬Coronavirus disease
| Deucravacitinib | 036 [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬72. Coronavirus disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 73 | Cushing syndrome 💬 23 genes, 56 drugs (DrugBank) and 71 diseases |
EGFR [1] EGFR 💬Cushing syndrome
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Cushing syndrome
| Erlotinib | 094 [2] 94, 160 💬73. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 74 | Cushing syndrome 💬 23 genes, 56 drugs (DrugBank) and 71 diseases |
EGFR [1] EGFR 💬Cushing syndrome
|
Erlotinib Erlotinib 💬Cushing syndrome
| Erlotinib | 094 [2] 94, 160 💬73. Cushing syndrome
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 75 | Cytokine-cytokine receptor interaction 💬 90 genes, 141 drugs (DrugBank) and 104 diseases |
IL12A [3] IL12A, IL12B, IL23A 💬
|
Ustekinumab Ustekinumab 💬Cytokine-cytokine receptor interaction
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬75. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 76 | Cytokine-cytokine receptor interaction 💬 90 genes, 141 drugs (DrugBank) and 104 diseases |
IL17A [1] IL17A 💬Cytokine-cytokine receptor interaction
|
Ixekizumab Ixekizumab 💬Cytokine-cytokine receptor interaction
| Ixekizumab | 036 [8] 36, 37, 46, 107, 160, 162, 269, 271 💬76. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 77 | Cytokine-cytokine receptor interaction 💬 90 genes, 141 drugs (DrugBank) and 104 diseases |
IL17A [1] IL17A 💬Cytokine-cytokine receptor interaction
|
Secukinumab Secukinumab 💬Cytokine-cytokine receptor interaction
| Secukinumab | 013 [9] 13, 37, 40, 41, 46, 107, 160, 269, 271 💬77. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 78 | Cytokine-cytokine receptor interaction 💬 90 genes, 141 drugs (DrugBank) and 104 diseases |
IL1RL2 [1] IL1RL2 💬Cytokine-cytokine receptor interaction
|
Spesolimab Spesolimab 💬Cytokine-cytokine receptor interaction
| Spesolimab | 037 [5] 37, 96, 97, 160, 269 💬78. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 79 | Cytokine-cytokine receptor interaction 💬 90 genes, 141 drugs (DrugBank) and 104 diseases |
IL4R [1] IL4R 💬Cytokine-cytokine receptor interaction
|
Dupilumab Dupilumab 💬Cytokine-cytokine receptor interaction
| Dupilumab | 051 [8] 51, 97, 98, 160, 162, 222, 300, 306 💬79. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 80 | Cytokine-cytokine receptor interaction 💬 90 genes, 141 drugs (DrugBank) and 104 diseases |
TNF [1] TNF 💬Cytokine-cytokine receptor interaction
|
Adalimumab Adalimumab 💬Cytokine-cytokine receptor interaction
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬80. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 81 | Diabetic cardiomyopathy 💬 25 genes, 48 drugs (DrugBank) and 80 diseases |
PPARA [1] PPARA 💬Diabetic cardiomyopathy
|
Bezafibrate Bezafibrate 💬Diabetic cardiomyopathy
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬81. Diabetic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 82 | Dilated cardiomyopathy 💬 23 genes, 61 drugs (DrugBank) and 93 diseases |
TNF [1] TNF 💬Dilated cardiomyopathy
|
Adalimumab Adalimumab 💬Dilated cardiomyopathy
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬82. Dilated cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 83 | Dopaminergic synapse 💬 33 genes, 105 drugs (DrugBank) and 105 diseases |
PPP3CA [3] PPP3CA, PPP3CB, PPP3CC 💬
|
Pimecrolimus Pimecrolimus 💬Dopaminergic synapse
| Pimecrolimus | 160 [1] 160 💬83. Dopaminergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 84 | Efferocytosis 💬 30 genes, 78 drugs (DrugBank) and 97 diseases |
ALOX5 [1] ALOX5 💬Efferocytosis
|
Zileuton Zileuton 💬Efferocytosis
| Zileuton | 085 [3] 85, 160, 164 💬84. Efferocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 85 | Endocytosis 💬 25 genes, 41 drugs (DrugBank) and 54 diseases |
EGFR [1] EGFR 💬Endocytosis
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Endocytosis
| Erlotinib | 094 [2] 94, 160 💬85. Endocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 86 | Endocytosis 💬 25 genes, 41 drugs (DrugBank) and 54 diseases |
EGFR [1] EGFR 💬Endocytosis
|
Erlotinib Erlotinib 💬Endocytosis
| Erlotinib | 094 [2] 94, 160 💬85. Endocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 87 | Endometrial cancer 💬 10 genes, 19 drugs (DrugBank) and 28 diseases |
EGFR [1] EGFR 💬Endometrial cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Endometrial cancer
| Erlotinib | 094 [2] 94, 160 💬87. Endometrial cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 88 | Endometrial cancer 💬 10 genes, 19 drugs (DrugBank) and 28 diseases |
EGFR [1] EGFR 💬Endometrial cancer
|
Erlotinib Erlotinib 💬Endometrial cancer
| Erlotinib | 094 [2] 94, 160 💬87. Endometrial cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 89 | Epithelial cell signaling in Helicobacter pylori infection 💬 12 genes, 19 drugs (DrugBank) and 30 diseases |
EGFR [1] EGFR 💬Epithelial cell signaling in Helicobacter pylori infection
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Epithelial cell signaling in Helicobacter pylori infection
| Erlotinib | 094 [2] 94, 160 💬89. Epithelial cell signaling in Helicobacter pylori infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 90 | Epithelial cell signaling in Helicobacter pylori infection 💬 12 genes, 19 drugs (DrugBank) and 30 diseases |
EGFR [1] EGFR 💬Epithelial cell signaling in Helicobacter pylori infection
|
Erlotinib Erlotinib 💬Epithelial cell signaling in Helicobacter pylori infection
| Erlotinib | 094 [2] 94, 160 💬89. Epithelial cell signaling in Helicobacter pylori infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 91 | Epstein-Barr virus infection 💬 67 genes, 97 drugs (DrugBank) and 83 diseases |
TNF [1] TNF 💬Epstein-Barr virus infection
|
Adalimumab Adalimumab 💬Epstein-Barr virus infection
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬91. Epstein-Barr virus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 92 | Epstein-Barr virus infection 💬 67 genes, 97 drugs (DrugBank) and 83 diseases |
TYK2 [1] TYK2 💬Epstein-Barr virus infection
|
Deucravacitinib Deucravacitinib 💬Epstein-Barr virus infection
| Deucravacitinib | 036 [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬92. Epstein-Barr virus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 93 | ErbB signaling pathway 💬 14 genes, 27 drugs (DrugBank) and 65 diseases |
EGFR [1] EGFR 💬ErbB signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬ErbB signaling pathway
| Erlotinib | 094 [2] 94, 160 💬93. ErbB signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 94 | ErbB signaling pathway 💬 14 genes, 27 drugs (DrugBank) and 65 diseases |
EGFR [1] EGFR 💬ErbB signaling pathway
|
Erlotinib Erlotinib 💬ErbB signaling pathway
| Erlotinib | 094 [2] 94, 160 💬93. ErbB signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 95 | Estrogen signaling pathway 💬 20 genes, 80 drugs (DrugBank) and 70 diseases |
EGFR [1] EGFR 💬Estrogen signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Estrogen signaling pathway
| Erlotinib | 094 [2] 94, 160 💬95. Estrogen signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 96 | Estrogen signaling pathway 💬 20 genes, 80 drugs (DrugBank) and 70 diseases |
EGFR [1] EGFR 💬Estrogen signaling pathway
|
Erlotinib Erlotinib 💬Estrogen signaling pathway
| Erlotinib | 094 [2] 94, 160 💬95. Estrogen signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 97 | Estrogen signaling pathway 💬 20 genes, 80 drugs (DrugBank) and 70 diseases |
RARA [1] RARA 💬Estrogen signaling pathway
|
Isotretinoin Isotretinoin 💬Estrogen signaling pathway
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬97. Estrogen signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 98 | Fc epsilon RI signaling pathway 💬 19 genes, 49 drugs (DrugBank) and 71 diseases |
ALOX5 [1] ALOX5 💬Fc epsilon RI signaling pathway
|
Zileuton Zileuton 💬Fc epsilon RI signaling pathway
| Zileuton | 085 [3] 85, 160, 164 💬98. Fc epsilon RI signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 99 | Fc epsilon RI signaling pathway 💬 19 genes, 49 drugs (DrugBank) and 71 diseases |
TNF [1] TNF 💬Fc epsilon RI signaling pathway
|
Adalimumab Adalimumab 💬Fc epsilon RI signaling pathway
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬99. Fc epsilon RI signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 100 | Fluid shear stress and atherosclerosis 💬 33 genes, 60 drugs (DrugBank) and 100 diseases |
TNF [1] TNF 💬Fluid shear stress and atherosclerosis
|
Adalimumab Adalimumab 💬Fluid shear stress and atherosclerosis
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬100. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 101 | Focal adhesion 💬 31 genes, 52 drugs (DrugBank) and 54 diseases |
EGFR [1] EGFR 💬Focal adhesion
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Focal adhesion
| Erlotinib | 094 [2] 94, 160 💬101. Focal adhesion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 102 | Focal adhesion 💬 31 genes, 52 drugs (DrugBank) and 54 diseases |
EGFR [1] EGFR 💬Focal adhesion
|
Erlotinib Erlotinib 💬Focal adhesion
| Erlotinib | 094 [2] 94, 160 💬101. Focal adhesion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 103 | FoxO signaling pathway 💬 26 genes, 43 drugs (DrugBank) and 62 diseases |
EGFR [1] EGFR 💬FoxO signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬FoxO signaling pathway
| Erlotinib | 094 [2] 94, 160 💬103. FoxO signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 104 | FoxO signaling pathway 💬 26 genes, 43 drugs (DrugBank) and 62 diseases |
EGFR [1] EGFR 💬FoxO signaling pathway
|
Erlotinib Erlotinib 💬FoxO signaling pathway
| Erlotinib | 094 [2] 94, 160 💬103. FoxO signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 105 | Gap junction 💬 27 genes, 103 drugs (DrugBank) and 87 diseases |
EGFR [1] EGFR 💬Gap junction
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Gap junction
| Erlotinib | 094 [2] 94, 160 💬105. Gap junction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 106 | Gap junction 💬 27 genes, 103 drugs (DrugBank) and 87 diseases |
EGFR [1] EGFR 💬Gap junction
|
Erlotinib Erlotinib 💬Gap junction
| Erlotinib | 094 [2] 94, 160 💬105. Gap junction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 107 | Gastric cancer 💬 23 genes, 41 drugs (DrugBank) and 69 diseases |
EGFR [1] EGFR 💬Gastric cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Gastric cancer
| Erlotinib | 094 [2] 94, 160 💬107. Gastric cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 108 | Gastric cancer 💬 23 genes, 41 drugs (DrugBank) and 69 diseases |
EGFR [1] EGFR 💬Gastric cancer
|
Erlotinib Erlotinib 💬Gastric cancer
| Erlotinib | 094 [2] 94, 160 💬107. Gastric cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 109 | Gastric cancer 💬 23 genes, 41 drugs (DrugBank) and 69 diseases |
RARB [1] RARB 💬Gastric cancer
|
Isotretinoin Isotretinoin 💬Gastric cancer
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬109. Gastric cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 110 | Glioma 💬 15 genes, 34 drugs (DrugBank) and 67 diseases |
EGFR [1] EGFR 💬Glioma
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Glioma
| Erlotinib | 094 [2] 94, 160 💬110. Glioma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 111 | Glioma 💬 15 genes, 34 drugs (DrugBank) and 67 diseases |
EGFR [1] EGFR 💬Glioma
|
Erlotinib Erlotinib 💬Glioma
| Erlotinib | 094 [2] 94, 160 💬110. Glioma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 112 | Glucagon signaling pathway 💬 15 genes, 26 drugs (DrugBank) and 85 diseases |
PPARA [1] PPARA 💬Glucagon signaling pathway
|
Bezafibrate Bezafibrate 💬Glucagon signaling pathway
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬112. Glucagon signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 113 | Glucagon signaling pathway 💬 15 genes, 26 drugs (DrugBank) and 85 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Glucagon signaling pathway
|
Pimecrolimus Pimecrolimus 💬Glucagon signaling pathway
| Pimecrolimus | 160 [1] 160 💬113. Glucagon signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 114 | Glutamatergic synapse 💬 23 genes, 32 drugs (DrugBank) and 82 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Glutamatergic synapse
|
Pimecrolimus Pimecrolimus 💬Glutamatergic synapse
| Pimecrolimus | 160 [1] 160 💬114. Glutamatergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 115 | GnRH signaling pathway 💬 16 genes, 40 drugs (DrugBank) and 47 diseases |
EGFR [1] EGFR 💬GnRH signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬GnRH signaling pathway
| Erlotinib | 094 [2] 94, 160 💬115. GnRH signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 116 | GnRH signaling pathway 💬 16 genes, 40 drugs (DrugBank) and 47 diseases |
EGFR [1] EGFR 💬GnRH signaling pathway
|
Erlotinib Erlotinib 💬GnRH signaling pathway
| Erlotinib | 094 [2] 94, 160 💬115. GnRH signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 117 | Graft-versus-host disease 💬 28 genes, 26 drugs (DrugBank) and 68 diseases |
CD80 [2] CD80, CD86 💬
|
Abatacept Abatacept 💬Graft-versus-host disease
| Abatacept | 002 [28] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬117. Graft-versus-host disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 118 | Graft-versus-host disease 💬 28 genes, 26 drugs (DrugBank) and 68 diseases |
TNF [1] TNF 💬Graft-versus-host disease
|
Adalimumab Adalimumab 💬Graft-versus-host disease
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬118. Graft-versus-host disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 119 | Hematopoietic cell lineage 💬 47 genes, 97 drugs (DrugBank) and 101 diseases |
IL4R [1] IL4R 💬Hematopoietic cell lineage
|
Dupilumab Dupilumab 💬Hematopoietic cell lineage
| Dupilumab | 051 [8] 51, 97, 98, 160, 162, 222, 300, 306 💬119. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 120 | Hematopoietic cell lineage 💬 47 genes, 97 drugs (DrugBank) and 101 diseases |
TNF [1] TNF 💬Hematopoietic cell lineage
|
Adalimumab Adalimumab 💬Hematopoietic cell lineage
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬120. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 121 | Hepatitis B 💬 44 genes, 70 drugs (DrugBank) and 92 diseases |
TNF [1] TNF 💬Hepatitis B
|
Adalimumab Adalimumab 💬Hepatitis B
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬121. Hepatitis B
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 122 | Hepatitis B 💬 44 genes, 70 drugs (DrugBank) and 92 diseases |
TYK2 [1] TYK2 💬Hepatitis B
|
Deucravacitinib Deucravacitinib 💬Hepatitis B
| Deucravacitinib | 036 [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬122. Hepatitis B
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 123 | Hepatitis C 💬 37 genes, 75 drugs (DrugBank) and 92 diseases |
EGFR [1] EGFR 💬Hepatitis C
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Hepatitis C
| Erlotinib | 094 [2] 94, 160 💬123. Hepatitis C
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 124 | Hepatitis C 💬 37 genes, 75 drugs (DrugBank) and 92 diseases |
EGFR [1] EGFR 💬Hepatitis C
|
Erlotinib Erlotinib 💬Hepatitis C
| Erlotinib | 094 [2] 94, 160 💬123. Hepatitis C
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 125 | Hepatitis C 💬 37 genes, 75 drugs (DrugBank) and 92 diseases |
PPARA [1] PPARA 💬Hepatitis C
|
Bezafibrate Bezafibrate 💬Hepatitis C
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬125. Hepatitis C
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 126 | Hepatitis C 💬 37 genes, 75 drugs (DrugBank) and 92 diseases |
TNF [1] TNF 💬Hepatitis C
|
Adalimumab Adalimumab 💬Hepatitis C
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬126. Hepatitis C
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 127 | Hepatitis C 💬 37 genes, 75 drugs (DrugBank) and 92 diseases |
TYK2 [1] TYK2 💬Hepatitis C
|
Deucravacitinib Deucravacitinib 💬Hepatitis C
| Deucravacitinib | 036 [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬127. Hepatitis C
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 128 | Hepatocellular carcinoma 💬 22 genes, 33 drugs (DrugBank) and 70 diseases |
EGFR [1] EGFR 💬Hepatocellular carcinoma
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Hepatocellular carcinoma
| Erlotinib | 094 [2] 94, 160 💬128. Hepatocellular carcinoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 129 | Hepatocellular carcinoma 💬 22 genes, 33 drugs (DrugBank) and 70 diseases |
EGFR [1] EGFR 💬Hepatocellular carcinoma
|
Erlotinib Erlotinib 💬Hepatocellular carcinoma
| Erlotinib | 094 [2] 94, 160 💬128. Hepatocellular carcinoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 130 | Herpes simplex virus 1 infection 💬 71 genes, 85 drugs (DrugBank) and 110 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Herpes simplex virus 1 infection
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬130. Herpes simplex virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 131 | Herpes simplex virus 1 infection 💬 71 genes, 85 drugs (DrugBank) and 110 diseases |
TNF [1] TNF 💬Herpes simplex virus 1 infection
|
Adalimumab Adalimumab 💬Herpes simplex virus 1 infection
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬131. Herpes simplex virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 132 | Herpes simplex virus 1 infection 💬 71 genes, 85 drugs (DrugBank) and 110 diseases |
TYK2 [1] TYK2 💬Herpes simplex virus 1 infection
|
Deucravacitinib Deucravacitinib 💬Herpes simplex virus 1 infection
| Deucravacitinib | 036 [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬132. Herpes simplex virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 133 | HIF-1 signaling pathway 💬 26 genes, 56 drugs (DrugBank) and 87 diseases |
EGFR [1] EGFR 💬HIF-1 signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬HIF-1 signaling pathway
| Erlotinib | 094 [2] 94, 160 💬133. HIF-1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 134 | HIF-1 signaling pathway 💬 26 genes, 56 drugs (DrugBank) and 87 diseases |
EGFR [1] EGFR 💬HIF-1 signaling pathway
|
Erlotinib Erlotinib 💬HIF-1 signaling pathway
| Erlotinib | 094 [2] 94, 160 💬133. HIF-1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 135 | Human cytomegalovirus infection 💬 65 genes, 121 drugs (DrugBank) and 136 diseases |
EGFR [1] EGFR 💬Human cytomegalovirus infection
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Human cytomegalovirus infection
| Erlotinib | 094 [2] 94, 160 💬135. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 136 | Human cytomegalovirus infection 💬 65 genes, 121 drugs (DrugBank) and 136 diseases |
EGFR [1] EGFR 💬Human cytomegalovirus infection
|
Erlotinib Erlotinib 💬Human cytomegalovirus infection
| Erlotinib | 094 [2] 94, 160 💬135. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 137 | Human cytomegalovirus infection 💬 65 genes, 121 drugs (DrugBank) and 136 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Human cytomegalovirus infection
|
Pimecrolimus Pimecrolimus 💬Human cytomegalovirus infection
| Pimecrolimus | 160 [1] 160 💬137. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 138 | Human cytomegalovirus infection 💬 65 genes, 121 drugs (DrugBank) and 136 diseases |
TNF [1] TNF 💬Human cytomegalovirus infection
|
Adalimumab Adalimumab 💬Human cytomegalovirus infection
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬138. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 139 | Human immunodeficiency virus 1 infection 💬 51 genes, 59 drugs (DrugBank) and 98 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Human immunodeficiency virus 1 infection
|
Pimecrolimus Pimecrolimus 💬Human immunodeficiency virus 1 infection
| Pimecrolimus | 160 [1] 160 💬139. Human immunodeficiency virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 140 | Human immunodeficiency virus 1 infection 💬 51 genes, 59 drugs (DrugBank) and 98 diseases |
TNF [1] TNF 💬Human immunodeficiency virus 1 infection
|
Adalimumab Adalimumab 💬Human immunodeficiency virus 1 infection
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬140. Human immunodeficiency virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 141 | Human papillomavirus infection 💬 52 genes, 114 drugs (DrugBank) and 121 diseases |
EGFR [1] EGFR 💬Human papillomavirus infection
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Human papillomavirus infection
| Erlotinib | 094 [2] 94, 160 💬141. Human papillomavirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 142 | Human papillomavirus infection 💬 52 genes, 114 drugs (DrugBank) and 121 diseases |
EGFR [1] EGFR 💬Human papillomavirus infection
|
Erlotinib Erlotinib 💬Human papillomavirus infection
| Erlotinib | 094 [2] 94, 160 💬141. Human papillomavirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 143 | Human papillomavirus infection 💬 52 genes, 114 drugs (DrugBank) and 121 diseases |
TNF [1] TNF 💬Human papillomavirus infection
|
Adalimumab Adalimumab 💬Human papillomavirus infection
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬143. Human papillomavirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 144 | Human papillomavirus infection 💬 52 genes, 114 drugs (DrugBank) and 121 diseases |
TYK2 [1] TYK2 💬Human papillomavirus infection
|
Deucravacitinib Deucravacitinib 💬Human papillomavirus infection
| Deucravacitinib | 036 [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬144. Human papillomavirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 145 | Human T-cell leukemia virus 1 infection 💬 61 genes, 80 drugs (DrugBank) and 105 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Human T-cell leukemia virus 1 infection
|
Pimecrolimus Pimecrolimus 💬Human T-cell leukemia virus 1 infection
| Pimecrolimus | 160 [1] 160 💬145. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 146 | Human T-cell leukemia virus 1 infection 💬 61 genes, 80 drugs (DrugBank) and 105 diseases |
TNF [1] TNF 💬Human T-cell leukemia virus 1 infection
|
Adalimumab Adalimumab 💬Human T-cell leukemia virus 1 infection
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬146. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 147 | Hypertrophic cardiomyopathy 💬 26 genes, 57 drugs (DrugBank) and 97 diseases |
TNF [1] TNF 💬Hypertrophic cardiomyopathy
|
Adalimumab Adalimumab 💬Hypertrophic cardiomyopathy
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬147. Hypertrophic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 148 | IgSF CAM signaling 💬 45 genes, 68 drugs (DrugBank) and 91 diseases |
CD80 [2] CD80, CD86 💬
|
Abatacept Abatacept 💬IgSF CAM signaling
| Abatacept | 002 [28] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬148. IgSF CAM signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 149 | IL-17 signaling pathway 💬 20 genes, 65 drugs (DrugBank) and 91 diseases |
IL17A [1] IL17A 💬IL-17 signaling pathway
|
Ixekizumab Ixekizumab 💬IL-17 signaling pathway
| Ixekizumab | 036 [8] 36, 37, 46, 107, 160, 162, 269, 271 💬149. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 150 | IL-17 signaling pathway 💬 20 genes, 65 drugs (DrugBank) and 91 diseases |
IL17A [1] IL17A 💬IL-17 signaling pathway
|
Secukinumab Secukinumab 💬IL-17 signaling pathway
| Secukinumab | 013 [9] 13, 37, 40, 41, 46, 107, 160, 269, 271 💬150. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 151 | IL-17 signaling pathway 💬 20 genes, 65 drugs (DrugBank) and 91 diseases |
TNF [1] TNF 💬IL-17 signaling pathway
|
Adalimumab Adalimumab 💬IL-17 signaling pathway
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬151. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 152 | Inflammatory bowel disease 💬 38 genes, 49 drugs (DrugBank) and 75 diseases |
IL12A [3] IL12A, IL12B, IL23A 💬
|
Ustekinumab Ustekinumab 💬Inflammatory bowel disease
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬152. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 153 | Inflammatory bowel disease 💬 38 genes, 49 drugs (DrugBank) and 75 diseases |
IL17A [1] IL17A 💬Inflammatory bowel disease
|
Ixekizumab Ixekizumab 💬Inflammatory bowel disease
| Ixekizumab | 036 [8] 36, 37, 46, 107, 160, 162, 269, 271 💬153. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 154 | Inflammatory bowel disease 💬 38 genes, 49 drugs (DrugBank) and 75 diseases |
IL17A [1] IL17A 💬Inflammatory bowel disease
|
Secukinumab Secukinumab 💬Inflammatory bowel disease
| Secukinumab | 013 [9] 13, 37, 40, 41, 46, 107, 160, 269, 271 💬154. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 155 | Inflammatory bowel disease 💬 38 genes, 49 drugs (DrugBank) and 75 diseases |
IL4R [1] IL4R 💬Inflammatory bowel disease
|
Dupilumab Dupilumab 💬Inflammatory bowel disease
| Dupilumab | 051 [8] 51, 97, 98, 160, 162, 222, 300, 306 💬155. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 156 | Inflammatory bowel disease 💬 38 genes, 49 drugs (DrugBank) and 75 diseases |
TNF [1] TNF 💬Inflammatory bowel disease
|
Adalimumab Adalimumab 💬Inflammatory bowel disease
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬156. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 157 | Influenza A 💬 67 genes, 84 drugs (DrugBank) and 101 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Influenza A
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬157. Influenza A
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 158 | Influenza A 💬 67 genes, 84 drugs (DrugBank) and 101 diseases |
TNF [1] TNF 💬Influenza A
|
Adalimumab Adalimumab 💬Influenza A
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬158. Influenza A
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 159 | Influenza A 💬 67 genes, 84 drugs (DrugBank) and 101 diseases |
TYK2 [1] TYK2 💬Influenza A
|
Deucravacitinib Deucravacitinib 💬Influenza A
| Deucravacitinib | 036 [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬159. Influenza A
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 160 | Insulin resistance 💬 19 genes, 38 drugs (DrugBank) and 104 diseases |
PPARA [1] PPARA 💬Insulin resistance
|
Bezafibrate Bezafibrate 💬Insulin resistance
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬160. Insulin resistance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 161 | Insulin resistance 💬 19 genes, 38 drugs (DrugBank) and 104 diseases |
TNF [1] TNF 💬Insulin resistance
|
Adalimumab Adalimumab 💬Insulin resistance
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬161. Insulin resistance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 162 | Integrin signaling 💬 28 genes, 48 drugs (DrugBank) and 77 diseases |
EGFR [1] EGFR 💬Integrin signaling
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Integrin signaling
| Erlotinib | 094 [2] 94, 160 💬162. Integrin signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 163 | Integrin signaling 💬 28 genes, 48 drugs (DrugBank) and 77 diseases |
EGFR [1] EGFR 💬Integrin signaling
|
Erlotinib Erlotinib 💬Integrin signaling
| Erlotinib | 094 [2] 94, 160 💬162. Integrin signaling
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 164 | Intestinal immune network for IgA production 💬 33 genes, 40 drugs (DrugBank) and 53 diseases |
CD80 [2] CD80, CD86 💬
|
Abatacept Abatacept 💬Intestinal immune network for IgA production
| Abatacept | 002 [28] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬164. Intestinal immune network for IgA production
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 165 | JAK-STAT signaling pathway 💬 60 genes, 117 drugs (DrugBank) and 116 diseases |
EGFR [1] EGFR 💬JAK-STAT signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬JAK-STAT signaling pathway
| Erlotinib | 094 [2] 94, 160 💬165. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 166 | JAK-STAT signaling pathway 💬 60 genes, 117 drugs (DrugBank) and 116 diseases |
EGFR [1] EGFR 💬JAK-STAT signaling pathway
|
Erlotinib Erlotinib 💬JAK-STAT signaling pathway
| Erlotinib | 094 [2] 94, 160 💬165. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 167 | JAK-STAT signaling pathway 💬 60 genes, 117 drugs (DrugBank) and 116 diseases |
IL12A [3] IL12A, IL12B, IL23A 💬
|
Ustekinumab Ustekinumab 💬JAK-STAT signaling pathway
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬167. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 168 | JAK-STAT signaling pathway 💬 60 genes, 117 drugs (DrugBank) and 116 diseases |
IL4R [1] IL4R 💬JAK-STAT signaling pathway
|
Dupilumab Dupilumab 💬JAK-STAT signaling pathway
| Dupilumab | 051 [8] 51, 97, 98, 160, 162, 222, 300, 306 💬168. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 169 | JAK-STAT signaling pathway 💬 60 genes, 117 drugs (DrugBank) and 116 diseases |
TYK2 [1] TYK2 💬JAK-STAT signaling pathway
|
Deucravacitinib Deucravacitinib 💬JAK-STAT signaling pathway
| Deucravacitinib | 036 [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬169. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 170 | Kaposi sarcoma-associated herpesvirus infection 💬 61 genes, 102 drugs (DrugBank) and 124 diseases |
CD86 [1] CD86 💬Kaposi sarcoma-associated herpesvirus infection
|
Abatacept Abatacept 💬Kaposi sarcoma-associated herpesvirus infection
| Abatacept | 002 [28] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬170. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 171 | Kaposi sarcoma-associated herpesvirus infection 💬 61 genes, 102 drugs (DrugBank) and 124 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Kaposi sarcoma-associated herpesvirus infection
|
Pimecrolimus Pimecrolimus 💬Kaposi sarcoma-associated herpesvirus infection
| Pimecrolimus | 160 [1] 160 💬171. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 172 | Kaposi sarcoma-associated herpesvirus infection 💬 61 genes, 102 drugs (DrugBank) and 124 diseases |
TYK2 [1] TYK2 💬Kaposi sarcoma-associated herpesvirus infection
|
Deucravacitinib Deucravacitinib 💬Kaposi sarcoma-associated herpesvirus infection
| Deucravacitinib | 036 [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬172. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 173 | Legionellosis 💬 10 genes, 24 drugs (DrugBank) and 68 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Legionellosis
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬173. Legionellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 174 | Legionellosis 💬 10 genes, 24 drugs (DrugBank) and 68 diseases |
TNF [1] TNF 💬Legionellosis
|
Adalimumab Adalimumab 💬Legionellosis
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬174. Legionellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 175 | Leishmaniasis 💬 40 genes, 76 drugs (DrugBank) and 105 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Leishmaniasis
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬175. Leishmaniasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 176 | Leishmaniasis 💬 40 genes, 76 drugs (DrugBank) and 105 diseases |
TNF [1] TNF 💬Leishmaniasis
|
Adalimumab Adalimumab 💬Leishmaniasis
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬176. Leishmaniasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 177 | Lipid and atherosclerosis 💬 52 genes, 73 drugs (DrugBank) and 107 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Lipid and atherosclerosis
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬177. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 178 | Lipid and atherosclerosis 💬 52 genes, 73 drugs (DrugBank) and 107 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Lipid and atherosclerosis
|
Pimecrolimus Pimecrolimus 💬Lipid and atherosclerosis
| Pimecrolimus | 160 [1] 160 💬178. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 179 | Lipid and atherosclerosis 💬 52 genes, 73 drugs (DrugBank) and 107 diseases |
TNF [1] TNF 💬Lipid and atherosclerosis
|
Adalimumab Adalimumab 💬Lipid and atherosclerosis
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬179. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 180 | Long-term potentiation 💬 18 genes, 37 drugs (DrugBank) and 87 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Long-term potentiation
|
Pimecrolimus Pimecrolimus 💬Long-term potentiation
| Pimecrolimus | 160 [1] 160 💬180. Long-term potentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 181 | Malaria 💬 17 genes, 31 drugs (DrugBank) and 69 diseases |
IL12A [1] IL12A 💬Malaria
|
Ustekinumab Ustekinumab 💬Malaria
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬181. Malaria
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 182 | Malaria 💬 17 genes, 31 drugs (DrugBank) and 69 diseases |
TNF [1] TNF 💬Malaria
|
Adalimumab Adalimumab 💬Malaria
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬182. Malaria
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 183 | MAPK signaling pathway 💬 70 genes, 101 drugs (DrugBank) and 117 diseases |
EGFR [1] EGFR 💬MAPK signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬MAPK signaling pathway
| Erlotinib | 094 [2] 94, 160 💬183. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 184 | MAPK signaling pathway 💬 70 genes, 101 drugs (DrugBank) and 117 diseases |
EGFR [1] EGFR 💬MAPK signaling pathway
|
Erlotinib Erlotinib 💬MAPK signaling pathway
| Erlotinib | 094 [2] 94, 160 💬183. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 185 | MAPK signaling pathway 💬 70 genes, 101 drugs (DrugBank) and 117 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬MAPK signaling pathway
|
Pimecrolimus Pimecrolimus 💬MAPK signaling pathway
| Pimecrolimus | 160 [1] 160 💬185. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 186 | MAPK signaling pathway 💬 70 genes, 101 drugs (DrugBank) and 117 diseases |
TNF [1] TNF 💬MAPK signaling pathway
|
Adalimumab Adalimumab 💬MAPK signaling pathway
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬186. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 187 | Measles 💬 42 genes, 72 drugs (DrugBank) and 70 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Measles
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬187. Measles
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 188 | Measles 💬 42 genes, 72 drugs (DrugBank) and 70 diseases |
TYK2 [1] TYK2 💬Measles
|
Deucravacitinib Deucravacitinib 💬Measles
| Deucravacitinib | 036 [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬188. Measles
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 189 | Melanoma 💬 17 genes, 34 drugs (DrugBank) and 45 diseases |
EGFR [1] EGFR 💬Melanoma
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Melanoma
| Erlotinib | 094 [2] 94, 160 💬189. Melanoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 190 | Melanoma 💬 17 genes, 34 drugs (DrugBank) and 45 diseases |
EGFR [1] EGFR 💬Melanoma
|
Erlotinib Erlotinib 💬Melanoma
| Erlotinib | 094 [2] 94, 160 💬189. Melanoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 191 | MicroRNAs in cancer 💬 32 genes, 78 drugs (DrugBank) and 96 diseases |
EGFR [1] EGFR 💬MicroRNAs in cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬MicroRNAs in cancer
| Erlotinib | 094 [2] 94, 160 💬191. MicroRNAs in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 192 | MicroRNAs in cancer 💬 32 genes, 78 drugs (DrugBank) and 96 diseases |
EGFR [1] EGFR 💬MicroRNAs in cancer
|
Erlotinib Erlotinib 💬MicroRNAs in cancer
| Erlotinib | 094 [2] 94, 160 💬191. MicroRNAs in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 193 | mTOR signaling pathway 💬 15 genes, 33 drugs (DrugBank) and 99 diseases |
TNF [1] TNF 💬mTOR signaling pathway
|
Adalimumab Adalimumab 💬mTOR signaling pathway
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬193. mTOR signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 194 | Natural killer cell mediated cytotoxicity 💬 45 genes, 49 drugs (DrugBank) and 91 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Natural killer cell mediated cytotoxicity
|
Pimecrolimus Pimecrolimus 💬Natural killer cell mediated cytotoxicity
| Pimecrolimus | 160 [1] 160 💬194. Natural killer cell mediated cytotoxicity
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 195 | Natural killer cell mediated cytotoxicity 💬 45 genes, 49 drugs (DrugBank) and 91 diseases |
TNF [1] TNF 💬Natural killer cell mediated cytotoxicity
|
Adalimumab Adalimumab 💬Natural killer cell mediated cytotoxicity
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬195. Natural killer cell mediated cytotoxicity
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 196 | Necroptosis 💬 34 genes, 60 drugs (DrugBank) and 82 diseases |
TNF [1] TNF 💬Necroptosis
|
Adalimumab Adalimumab 💬Necroptosis
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬196. Necroptosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 197 | Necroptosis 💬 34 genes, 60 drugs (DrugBank) and 82 diseases |
TYK2 [1] TYK2 💬Necroptosis
|
Deucravacitinib Deucravacitinib 💬Necroptosis
| Deucravacitinib | 036 [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬197. Necroptosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 198 | NF-kappa B signaling pathway 💬 23 genes, 81 drugs (DrugBank) and 97 diseases |
TNF [1] TNF 💬NF-kappa B signaling pathway
|
Adalimumab Adalimumab 💬NF-kappa B signaling pathway
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬198. NF-kappa B signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 199 | NOD-like receptor signaling pathway 💬 33 genes, 57 drugs (DrugBank) and 79 diseases |
TNF [1] TNF 💬NOD-like receptor signaling pathway
|
Adalimumab Adalimumab 💬NOD-like receptor signaling pathway
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬199. NOD-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 200 | NOD-like receptor signaling pathway 💬 33 genes, 57 drugs (DrugBank) and 79 diseases |
TYK2 [1] TYK2 💬NOD-like receptor signaling pathway
|
Deucravacitinib Deucravacitinib 💬NOD-like receptor signaling pathway
| Deucravacitinib | 036 [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬200. NOD-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 201 | Non-alcoholic fatty liver disease 💬 24 genes, 54 drugs (DrugBank) and 100 diseases |
PPARA [1] PPARA 💬Non-alcoholic fatty liver disease
|
Bezafibrate Bezafibrate 💬Non-alcoholic fatty liver disease
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬201. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 202 | Non-alcoholic fatty liver disease 💬 24 genes, 54 drugs (DrugBank) and 100 diseases |
TNF [1] TNF 💬Non-alcoholic fatty liver disease
|
Adalimumab Adalimumab 💬Non-alcoholic fatty liver disease
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬202. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 203 | Non-small cell lung cancer 💬 21 genes, 39 drugs (DrugBank) and 57 diseases |
EGFR [1] EGFR 💬Non-small cell lung cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Non-small cell lung cancer
| Erlotinib | 094 [2] 94, 160 💬203. Non-small cell lung cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 204 | Non-small cell lung cancer 💬 21 genes, 39 drugs (DrugBank) and 57 diseases |
EGFR [1] EGFR 💬Non-small cell lung cancer
|
Erlotinib Erlotinib 💬Non-small cell lung cancer
| Erlotinib | 094 [2] 94, 160 💬203. Non-small cell lung cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 205 | Non-small cell lung cancer 💬 21 genes, 39 drugs (DrugBank) and 57 diseases |
RARB [1] RARB 💬Non-small cell lung cancer
|
Isotretinoin Isotretinoin 💬Non-small cell lung cancer
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬205. Non-small cell lung cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 206 | Oocyte meiosis 💬 14 genes, 39 drugs (DrugBank) and 73 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Oocyte meiosis
|
Pimecrolimus Pimecrolimus 💬Oocyte meiosis
| Pimecrolimus | 160 [1] 160 💬206. Oocyte meiosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 207 | Osteoclast differentiation 💬 40 genes, 93 drugs (DrugBank) and 109 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Osteoclast differentiation
|
Pimecrolimus Pimecrolimus 💬Osteoclast differentiation
| Pimecrolimus | 160 [1] 160 💬207. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 208 | Osteoclast differentiation 💬 40 genes, 93 drugs (DrugBank) and 109 diseases |
TNF [1] TNF 💬Osteoclast differentiation
|
Adalimumab Adalimumab 💬Osteoclast differentiation
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬208. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 209 | Osteoclast differentiation 💬 40 genes, 93 drugs (DrugBank) and 109 diseases |
TYK2 [1] TYK2 💬Osteoclast differentiation
|
Deucravacitinib Deucravacitinib 💬Osteoclast differentiation
| Deucravacitinib | 036 [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬209. Osteoclast differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 210 | Ovarian steroidogenesis 💬 7 genes, 40 drugs (DrugBank) and 53 diseases |
ALOX5 [1] ALOX5 💬Ovarian steroidogenesis
|
Zileuton Zileuton 💬Ovarian steroidogenesis
| Zileuton | 085 [3] 85, 160, 164 💬210. Ovarian steroidogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 211 | Oxytocin signaling pathway 💬 34 genes, 85 drugs (DrugBank) and 112 diseases |
EGFR [1] EGFR 💬Oxytocin signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Oxytocin signaling pathway
| Erlotinib | 094 [2] 94, 160 💬211. Oxytocin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 212 | Oxytocin signaling pathway 💬 34 genes, 85 drugs (DrugBank) and 112 diseases |
EGFR [1] EGFR 💬Oxytocin signaling pathway
|
Erlotinib Erlotinib 💬Oxytocin signaling pathway
| Erlotinib | 094 [2] 94, 160 💬211. Oxytocin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 213 | Oxytocin signaling pathway 💬 34 genes, 85 drugs (DrugBank) and 112 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Oxytocin signaling pathway
|
Pimecrolimus Pimecrolimus 💬Oxytocin signaling pathway
| Pimecrolimus | 160 [1] 160 💬213. Oxytocin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 214 | Pancreatic cancer 💬 20 genes, 43 drugs (DrugBank) and 86 diseases |
EGFR [1] EGFR 💬Pancreatic cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Pancreatic cancer
| Erlotinib | 094 [2] 94, 160 💬214. Pancreatic cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 215 | Pancreatic cancer 💬 20 genes, 43 drugs (DrugBank) and 86 diseases |
EGFR [1] EGFR 💬Pancreatic cancer
|
Erlotinib Erlotinib 💬Pancreatic cancer
| Erlotinib | 094 [2] 94, 160 💬214. Pancreatic cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 216 | Parathyroid hormone synthesis, secretion and action 💬 24 genes, 63 drugs (DrugBank) and 70 diseases |
EGFR [1] EGFR 💬Parathyroid hormone synthesis, secretion and action
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Parathyroid hormone synthesis, secretion and action
| Erlotinib | 094 [2] 94, 160 💬216. Parathyroid hormone synthesis, secretion and action
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 217 | Parathyroid hormone synthesis, secretion and action 💬 24 genes, 63 drugs (DrugBank) and 70 diseases |
EGFR [1] EGFR 💬Parathyroid hormone synthesis, secretion and action
|
Erlotinib Erlotinib 💬Parathyroid hormone synthesis, secretion and action
| Erlotinib | 094 [2] 94, 160 💬216. Parathyroid hormone synthesis, secretion and action
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 218 | Pathogenic Escherichia coli infection 💬 31 genes, 46 drugs (DrugBank) and 84 diseases |
TNF [1] TNF 💬Pathogenic Escherichia coli infection
|
Adalimumab Adalimumab 💬Pathogenic Escherichia coli infection
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬218. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 219 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
EGFR [1] EGFR 💬Pathways in cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Pathways in cancer
| Erlotinib | 094 [2] 94, 160 💬219. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 220 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
EGFR [1] EGFR 💬Pathways in cancer
|
Erlotinib Erlotinib 💬Pathways in cancer
| Erlotinib | 094 [2] 94, 160 💬219. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 221 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
IL12A [3] IL12A, IL12B, IL23A 💬
|
Ustekinumab Ustekinumab 💬Pathways in cancer
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬221. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 222 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
IL4R [1] IL4R 💬Pathways in cancer
|
Dupilumab Dupilumab 💬Pathways in cancer
| Dupilumab | 051 [8] 51, 97, 98, 160, 162, 222, 300, 306 💬222. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 223 | Pathways in cancer 💬 116 genes, 235 drugs (DrugBank) and 150 diseases |
RARA [2] RARA, RARB 💬
|
Isotretinoin Isotretinoin 💬Pathways in cancer
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬223. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 224 | Pathways of neurodegeneration - multiple diseases 💬 64 genes, 143 drugs (DrugBank) and 141 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Pathways of neurodegeneration - multiple diseases
|
Pimecrolimus Pimecrolimus 💬Pathways of neurodegeneration - multiple diseases
| Pimecrolimus | 160 [1] 160 💬224. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 225 | Pathways of neurodegeneration - multiple diseases 💬 64 genes, 143 drugs (DrugBank) and 141 diseases |
TNF [1] TNF 💬Pathways of neurodegeneration - multiple diseases
|
Adalimumab Adalimumab 💬Pathways of neurodegeneration - multiple diseases
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬225. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 226 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 34 genes, 70 drugs (DrugBank) and 104 diseases |
EGFR [1] EGFR 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Erlotinib | 094 [2] 94, 160 💬226. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 227 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 34 genes, 70 drugs (DrugBank) and 104 diseases |
EGFR [1] EGFR 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
|
Erlotinib Erlotinib 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Erlotinib | 094 [2] 94, 160 💬226. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 228 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 34 genes, 70 drugs (DrugBank) and 104 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
|
Pimecrolimus Pimecrolimus 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Pimecrolimus | 160 [1] 160 💬228. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 229 | Pertussis 💬 23 genes, 48 drugs (DrugBank) and 77 diseases |
IL12A [3] IL12A, IL12B, IL23A 💬
|
Ustekinumab Ustekinumab 💬Pertussis
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬229. Pertussis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 230 | Pertussis 💬 23 genes, 48 drugs (DrugBank) and 77 diseases |
TNF [1] TNF 💬Pertussis
|
Adalimumab Adalimumab 💬Pertussis
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬230. Pertussis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 231 | Phospholipase D signaling pathway 💬 24 genes, 60 drugs (DrugBank) and 84 diseases |
EGFR [1] EGFR 💬Phospholipase D signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Phospholipase D signaling pathway
| Erlotinib | 094 [2] 94, 160 💬231. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 232 | Phospholipase D signaling pathway 💬 24 genes, 60 drugs (DrugBank) and 84 diseases |
EGFR [1] EGFR 💬Phospholipase D signaling pathway
|
Erlotinib Erlotinib 💬Phospholipase D signaling pathway
| Erlotinib | 094 [2] 94, 160 💬231. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 233 | PI3K-Akt signaling pathway 💬 86 genes, 147 drugs (DrugBank) and 129 diseases |
EGFR [1] EGFR 💬PI3K-Akt signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬PI3K-Akt signaling pathway
| Erlotinib | 094 [2] 94, 160 💬233. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 234 | PI3K-Akt signaling pathway 💬 86 genes, 147 drugs (DrugBank) and 129 diseases |
EGFR [1] EGFR 💬PI3K-Akt signaling pathway
|
Erlotinib Erlotinib 💬PI3K-Akt signaling pathway
| Erlotinib | 094 [2] 94, 160 💬233. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 235 | PI3K-Akt signaling pathway 💬 86 genes, 147 drugs (DrugBank) and 129 diseases |
IL4R [1] IL4R 💬PI3K-Akt signaling pathway
|
Dupilumab Dupilumab 💬PI3K-Akt signaling pathway
| Dupilumab | 051 [8] 51, 97, 98, 160, 162, 222, 300, 306 💬235. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 236 | PPAR signaling pathway 💬 12 genes, 19 drugs (DrugBank) and 38 diseases |
PPARA [1] PPARA 💬PPAR signaling pathway
|
Bezafibrate Bezafibrate 💬PPAR signaling pathway
| Bezafibrate | 020 [8] 20, 93, 94, 160, 296, 316, 324, 344 💬236. PPAR signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 237 | Prion disease 💬 41 genes, 77 drugs (DrugBank) and 121 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Prion disease
|
Pimecrolimus Pimecrolimus 💬Prion disease
| Pimecrolimus | 160 [1] 160 💬237. Prion disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 238 | Prion disease 💬 41 genes, 77 drugs (DrugBank) and 121 diseases |
TNF [1] TNF 💬Prion disease
|
Adalimumab Adalimumab 💬Prion disease
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬238. Prion disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 239 | Prostate cancer 💬 24 genes, 58 drugs (DrugBank) and 92 diseases |
EGFR [1] EGFR 💬Prostate cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Prostate cancer
| Erlotinib | 094 [2] 94, 160 💬239. Prostate cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 240 | Prostate cancer 💬 24 genes, 58 drugs (DrugBank) and 92 diseases |
EGFR [1] EGFR 💬Prostate cancer
|
Erlotinib Erlotinib 💬Prostate cancer
| Erlotinib | 094 [2] 94, 160 💬239. Prostate cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 241 | Proteoglycans in cancer 💬 34 genes, 75 drugs (DrugBank) and 107 diseases |
EGFR [1] EGFR 💬Proteoglycans in cancer
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Proteoglycans in cancer
| Erlotinib | 094 [2] 94, 160 💬241. Proteoglycans in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 242 | Proteoglycans in cancer 💬 34 genes, 75 drugs (DrugBank) and 107 diseases |
EGFR [1] EGFR 💬Proteoglycans in cancer
|
Erlotinib Erlotinib 💬Proteoglycans in cancer
| Erlotinib | 094 [2] 94, 160 💬241. Proteoglycans in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 243 | Proteoglycans in cancer 💬 34 genes, 75 drugs (DrugBank) and 107 diseases |
IL12B [1] IL12B 💬Proteoglycans in cancer
|
Ustekinumab Ustekinumab 💬Proteoglycans in cancer
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬243. Proteoglycans in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 244 | Proteoglycans in cancer 💬 34 genes, 75 drugs (DrugBank) and 107 diseases |
TNF [1] TNF 💬Proteoglycans in cancer
|
Adalimumab Adalimumab 💬Proteoglycans in cancer
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬244. Proteoglycans in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 245 | Rap1 signaling pathway 💬 47 genes, 115 drugs (DrugBank) and 101 diseases |
EGFR [1] EGFR 💬Rap1 signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Rap1 signaling pathway
| Erlotinib | 094 [2] 94, 160 💬245. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 246 | Rap1 signaling pathway 💬 47 genes, 115 drugs (DrugBank) and 101 diseases |
EGFR [1] EGFR 💬Rap1 signaling pathway
|
Erlotinib Erlotinib 💬Rap1 signaling pathway
| Erlotinib | 094 [2] 94, 160 💬245. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 247 | Ras signaling pathway 💬 38 genes, 65 drugs (DrugBank) and 77 diseases |
EGFR [1] EGFR 💬Ras signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Ras signaling pathway
| Erlotinib | 094 [2] 94, 160 💬247. Ras signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 248 | Ras signaling pathway 💬 38 genes, 65 drugs (DrugBank) and 77 diseases |
EGFR [1] EGFR 💬Ras signaling pathway
|
Erlotinib Erlotinib 💬Ras signaling pathway
| Erlotinib | 094 [2] 94, 160 💬247. Ras signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 249 | Regulation of actin cytoskeleton 💬 37 genes, 82 drugs (DrugBank) and 79 diseases |
EGFR [1] EGFR 💬Regulation of actin cytoskeleton
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Regulation of actin cytoskeleton
| Erlotinib | 094 [2] 94, 160 💬249. Regulation of actin cytoskeleton
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 250 | Regulation of actin cytoskeleton 💬 37 genes, 82 drugs (DrugBank) and 79 diseases |
EGFR [1] EGFR 💬Regulation of actin cytoskeleton
|
Erlotinib Erlotinib 💬Regulation of actin cytoskeleton
| Erlotinib | 094 [2] 94, 160 💬249. Regulation of actin cytoskeleton
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 251 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 53 diseases |
EGFR [1] EGFR 💬Relaxin signaling pathway
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Relaxin signaling pathway
| Erlotinib | 094 [2] 94, 160 💬251. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 252 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 53 diseases |
EGFR [1] EGFR 💬Relaxin signaling pathway
|
Erlotinib Erlotinib 💬Relaxin signaling pathway
| Erlotinib | 094 [2] 94, 160 💬251. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 253 | Renin secretion 💬 28 genes, 90 drugs (DrugBank) and 108 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Renin secretion
|
Pimecrolimus Pimecrolimus 💬Renin secretion
| Pimecrolimus | 160 [1] 160 💬253. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 254 | Rheumatoid arthritis 💬 39 genes, 59 drugs (DrugBank) and 85 diseases |
CD80 [2] CD80, CD86 💬
|
Abatacept Abatacept 💬Rheumatoid arthritis
| Abatacept | 002 [28] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬254. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 255 | Rheumatoid arthritis 💬 39 genes, 59 drugs (DrugBank) and 85 diseases |
IL17A [1] IL17A 💬Rheumatoid arthritis
|
Ixekizumab Ixekizumab 💬Rheumatoid arthritis
| Ixekizumab | 036 [8] 36, 37, 46, 107, 160, 162, 269, 271 💬255. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 256 | Rheumatoid arthritis 💬 39 genes, 59 drugs (DrugBank) and 85 diseases |
IL17A [1] IL17A 💬Rheumatoid arthritis
|
Secukinumab Secukinumab 💬Rheumatoid arthritis
| Secukinumab | 013 [9] 13, 37, 40, 41, 46, 107, 160, 269, 271 💬256. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 257 | Rheumatoid arthritis 💬 39 genes, 59 drugs (DrugBank) and 85 diseases |
IL23A [1] IL23A 💬Rheumatoid arthritis
|
Ustekinumab Ustekinumab 💬Rheumatoid arthritis
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬257. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 258 | Rheumatoid arthritis 💬 39 genes, 59 drugs (DrugBank) and 85 diseases |
TNF [1] TNF 💬Rheumatoid arthritis
|
Adalimumab Adalimumab 💬Rheumatoid arthritis
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬258. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 259 | RIG-I-like receptor signaling pathway 💬 24 genes, 20 drugs (DrugBank) and 61 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬RIG-I-like receptor signaling pathway
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬259. RIG-I-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 260 | RIG-I-like receptor signaling pathway 💬 24 genes, 20 drugs (DrugBank) and 61 diseases |
TNF [1] TNF 💬RIG-I-like receptor signaling pathway
|
Adalimumab Adalimumab 💬RIG-I-like receptor signaling pathway
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬260. RIG-I-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 261 | Salmonella infection 💬 32 genes, 48 drugs (DrugBank) and 78 diseases |
TNF [1] TNF 💬Salmonella infection
|
Adalimumab Adalimumab 💬Salmonella infection
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬261. Salmonella infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 262 | Serotonergic synapse 💬 40 genes, 130 drugs (DrugBank) and 89 diseases |
ALOX5 [1] ALOX5 💬Serotonergic synapse
|
Zileuton Zileuton 💬Serotonergic synapse
| Zileuton | 085 [3] 85, 160, 164 💬262. Serotonergic synapse
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 263 | Shigellosis 💬 31 genes, 54 drugs (DrugBank) and 97 diseases |
EGFR [1] EGFR 💬Shigellosis
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Shigellosis
| Erlotinib | 094 [2] 94, 160 💬263. Shigellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 264 | Shigellosis 💬 31 genes, 54 drugs (DrugBank) and 97 diseases |
EGFR [1] EGFR 💬Shigellosis
|
Erlotinib Erlotinib 💬Shigellosis
| Erlotinib | 094 [2] 94, 160 💬263. Shigellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 265 | Shigellosis 💬 31 genes, 54 drugs (DrugBank) and 97 diseases |
TNF [1] TNF 💬Shigellosis
|
Adalimumab Adalimumab 💬Shigellosis
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬265. Shigellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 266 | Small cell lung cancer 💬 15 genes, 47 drugs (DrugBank) and 63 diseases |
RARB [1] RARB 💬Small cell lung cancer
|
Isotretinoin Isotretinoin 💬Small cell lung cancer
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬266. Small cell lung cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 267 | Sphingolipid signaling pathway 💬 32 genes, 56 drugs (DrugBank) and 84 diseases |
TNF [1] TNF 💬Sphingolipid signaling pathway
|
Adalimumab Adalimumab 💬Sphingolipid signaling pathway
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬267. Sphingolipid signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 268 | Systemic lupus erythematosus 💬 30 genes, 49 drugs (DrugBank) and 90 diseases |
CD80 [2] CD80, CD86 💬
|
Abatacept Abatacept 💬Systemic lupus erythematosus
| Abatacept | 002 [28] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬268. Systemic lupus erythematosus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 269 | Systemic lupus erythematosus 💬 30 genes, 49 drugs (DrugBank) and 90 diseases |
TNF [1] TNF 💬Systemic lupus erythematosus
|
Adalimumab Adalimumab 💬Systemic lupus erythematosus
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬269. Systemic lupus erythematosus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 270 | T cell receptor signaling pathway 💬 35 genes, 58 drugs (DrugBank) and 88 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬T cell receptor signaling pathway
|
Pimecrolimus Pimecrolimus 💬T cell receptor signaling pathway
| Pimecrolimus | 160 [1] 160 💬270. T cell receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 271 | T cell receptor signaling pathway 💬 35 genes, 58 drugs (DrugBank) and 88 diseases |
TNF [1] TNF 💬T cell receptor signaling pathway
|
Adalimumab Adalimumab 💬T cell receptor signaling pathway
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬271. T cell receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 272 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 62 diseases |
HMGCR [1] HMGCR 💬Terpenoid backbone biosynthesis
|
Atorvastatin calcium Atorvastatin calcium 💬Terpenoid backbone biosynthesis
| Atorvastatin | 013 [21] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬272. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 273 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 62 diseases |
HMGCR [1] HMGCR 💬Terpenoid backbone biosynthesis
|
Atorvastatin Atorvastatin 💬Terpenoid backbone biosynthesis
| Atorvastatin | 013 [21] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬272. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 274 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 62 diseases |
HMGCR [1] HMGCR 💬Terpenoid backbone biosynthesis
|
Lovastatin Lovastatin 💬Terpenoid backbone biosynthesis
| Lovastatin | 006 [11] 6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬274. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 275 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 62 diseases |
HMGCR [1] HMGCR 💬Terpenoid backbone biosynthesis
|
Simvastatin Simvastatin 💬Terpenoid backbone biosynthesis
| Simvastatin | 006 [22] 6 , 13, 15, 34, 46, 49, 51, 57, 66, 79, 86, 89, 94, 158, 160, 162, 195, 223, 265, 298, 299, 310 💬275. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 276 | TGF-beta signaling pathway 💬 15 genes, 29 drugs (DrugBank) and 70 diseases |
TNF [1] TNF 💬TGF-beta signaling pathway
|
Adalimumab Adalimumab 💬TGF-beta signaling pathway
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬276. TGF-beta signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 277 | Th1 and Th2 cell differentiation 💬 45 genes, 57 drugs (DrugBank) and 83 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Th1 and Th2 cell differentiation
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬277. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 278 | Th1 and Th2 cell differentiation 💬 45 genes, 57 drugs (DrugBank) and 83 diseases |
IL4R [1] IL4R 💬Th1 and Th2 cell differentiation
|
Dupilumab Dupilumab 💬Th1 and Th2 cell differentiation
| Dupilumab | 051 [8] 51, 97, 98, 160, 162, 222, 300, 306 💬278. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 279 | Th1 and Th2 cell differentiation 💬 45 genes, 57 drugs (DrugBank) and 83 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Th1 and Th2 cell differentiation
|
Pimecrolimus Pimecrolimus 💬Th1 and Th2 cell differentiation
| Pimecrolimus | 160 [1] 160 💬279. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 280 | Th1 and Th2 cell differentiation 💬 45 genes, 57 drugs (DrugBank) and 83 diseases |
TYK2 [1] TYK2 💬Th1 and Th2 cell differentiation
|
Deucravacitinib Deucravacitinib 💬Th1 and Th2 cell differentiation
| Deucravacitinib | 036 [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬280. Th1 and Th2 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 281 | Th17 cell differentiation 💬 57 genes, 88 drugs (DrugBank) and 111 diseases |
IL17A [1] IL17A 💬Th17 cell differentiation
|
Ixekizumab Ixekizumab 💬Th17 cell differentiation
| Ixekizumab | 036 [8] 36, 37, 46, 107, 160, 162, 269, 271 💬281. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 282 | Th17 cell differentiation 💬 57 genes, 88 drugs (DrugBank) and 111 diseases |
IL17A [1] IL17A 💬Th17 cell differentiation
|
Secukinumab Secukinumab 💬Th17 cell differentiation
| Secukinumab | 013 [9] 13, 37, 40, 41, 46, 107, 160, 269, 271 💬282. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 283 | Th17 cell differentiation 💬 57 genes, 88 drugs (DrugBank) and 111 diseases |
IL23A [1] IL23A 💬Th17 cell differentiation
|
Ustekinumab Ustekinumab 💬Th17 cell differentiation
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬283. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 284 | Th17 cell differentiation 💬 57 genes, 88 drugs (DrugBank) and 111 diseases |
IL4R [1] IL4R 💬Th17 cell differentiation
|
Dupilumab Dupilumab 💬Th17 cell differentiation
| Dupilumab | 051 [8] 51, 97, 98, 160, 162, 222, 300, 306 💬284. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 285 | Th17 cell differentiation 💬 57 genes, 88 drugs (DrugBank) and 111 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Th17 cell differentiation
|
Pimecrolimus Pimecrolimus 💬Th17 cell differentiation
| Pimecrolimus | 160 [1] 160 💬285. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 286 | Th17 cell differentiation 💬 57 genes, 88 drugs (DrugBank) and 111 diseases |
RARA [1] RARA 💬Th17 cell differentiation
|
Isotretinoin Isotretinoin 💬Th17 cell differentiation
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬286. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 287 | Th17 cell differentiation 💬 57 genes, 88 drugs (DrugBank) and 111 diseases |
TYK2 [1] TYK2 💬Th17 cell differentiation
|
Deucravacitinib Deucravacitinib 💬Th17 cell differentiation
| Deucravacitinib | 036 [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬287. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 288 | TNF signaling pathway 💬 25 genes, 64 drugs (DrugBank) and 95 diseases |
TNF [1] TNF 💬TNF signaling pathway
|
Adalimumab Adalimumab 💬TNF signaling pathway
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬288. TNF signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 289 | Toll-like receptor signaling pathway 💬 41 genes, 68 drugs (DrugBank) and 84 diseases |
CD80 [2] CD80, CD86 💬
|
Abatacept Abatacept 💬Toll-like receptor signaling pathway
| Abatacept | 002 [28] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬289. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 290 | Toll-like receptor signaling pathway 💬 41 genes, 68 drugs (DrugBank) and 84 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Toll-like receptor signaling pathway
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬290. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 291 | Toll-like receptor signaling pathway 💬 41 genes, 68 drugs (DrugBank) and 84 diseases |
TNF [1] TNF 💬Toll-like receptor signaling pathway
|
Adalimumab Adalimumab 💬Toll-like receptor signaling pathway
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬291. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 292 | Toll-like receptor signaling pathway 💬 41 genes, 68 drugs (DrugBank) and 84 diseases |
TYK2 [1] TYK2 💬Toll-like receptor signaling pathway
|
Deucravacitinib Deucravacitinib 💬Toll-like receptor signaling pathway
| Deucravacitinib | 036 [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬292. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 293 | Toxoplasmosis 💬 41 genes, 53 drugs (DrugBank) and 78 diseases |
ALOX5 [1] ALOX5 💬Toxoplasmosis
|
Zileuton Zileuton 💬Toxoplasmosis
| Zileuton | 085 [3] 85, 160, 164 💬293. Toxoplasmosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 294 | Toxoplasmosis 💬 41 genes, 53 drugs (DrugBank) and 78 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Toxoplasmosis
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬294. Toxoplasmosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 295 | Toxoplasmosis 💬 41 genes, 53 drugs (DrugBank) and 78 diseases |
TNF [1] TNF 💬Toxoplasmosis
|
Adalimumab Adalimumab 💬Toxoplasmosis
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬295. Toxoplasmosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 296 | Toxoplasmosis 💬 41 genes, 53 drugs (DrugBank) and 78 diseases |
TYK2 [1] TYK2 💬Toxoplasmosis
|
Deucravacitinib Deucravacitinib 💬Toxoplasmosis
| Deucravacitinib | 036 [10] 36, 37, 40, 49, 53, 84, 96, 97, 160, 269 💬296. Toxoplasmosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 297 | Transcriptional misregulation in cancer 💬 28 genes, 64 drugs (DrugBank) and 83 diseases |
CD86 [1] CD86 💬Transcriptional misregulation in cancer
|
Abatacept Abatacept 💬Transcriptional misregulation in cancer
| Abatacept | 002 [28] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬297. Transcriptional misregulation in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 298 | Transcriptional misregulation in cancer 💬 28 genes, 64 drugs (DrugBank) and 83 diseases |
RARA [1] RARA 💬Transcriptional misregulation in cancer
|
Isotretinoin Isotretinoin 💬Transcriptional misregulation in cancer
| Isotretinoin | 036 [4] 36, 39, 159, 160 💬298. Transcriptional misregulation in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 299 | Tuberculosis 💬 67 genes, 80 drugs (DrugBank) and 104 diseases |
IL12A [3] IL12A, IL12B, IL23A 💬
|
Ustekinumab Ustekinumab 💬Tuberculosis
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬299. Tuberculosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 300 | Tuberculosis 💬 67 genes, 80 drugs (DrugBank) and 104 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Tuberculosis
|
Pimecrolimus Pimecrolimus 💬Tuberculosis
| Pimecrolimus | 160 [1] 160 💬300. Tuberculosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 301 | Tuberculosis 💬 67 genes, 80 drugs (DrugBank) and 104 diseases |
TNF [1] TNF 💬Tuberculosis
|
Adalimumab Adalimumab 💬Tuberculosis
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬301. Tuberculosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 302 | Type I diabetes mellitus 💬 32 genes, 25 drugs (DrugBank) and 72 diseases |
CD80 [2] CD80, CD86 💬
|
Abatacept Abatacept 💬Type I diabetes mellitus
| Abatacept | 002 [28] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬302. Type I diabetes mellitus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 303 | Type I diabetes mellitus 💬 32 genes, 25 drugs (DrugBank) and 72 diseases |
IL12A [2] IL12A, IL12B 💬
|
Ustekinumab Ustekinumab 💬Type I diabetes mellitus
| Ustekinumab | 037 [17] 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271 💬303. Type I diabetes mellitus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 304 | Type I diabetes mellitus 💬 32 genes, 25 drugs (DrugBank) and 72 diseases |
TNF [1] TNF 💬Type I diabetes mellitus
|
Adalimumab Adalimumab 💬Type I diabetes mellitus
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬304. Type I diabetes mellitus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 305 | Type II diabetes mellitus 💬 15 genes, 44 drugs (DrugBank) and 100 diseases |
TNF [1] TNF 💬Type II diabetes mellitus
|
Adalimumab Adalimumab 💬Type II diabetes mellitus
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬305. Type II diabetes mellitus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 306 | VEGF signaling pathway 💬 22 genes, 58 drugs (DrugBank) and 94 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬VEGF signaling pathway
|
Pimecrolimus Pimecrolimus 💬VEGF signaling pathway
| Pimecrolimus | 160 [1] 160 💬306. VEGF signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 307 | Viral myocarditis 💬 34 genes, 25 drugs (DrugBank) and 49 diseases |
CD80 [2] CD80, CD86 💬
|
Abatacept Abatacept 💬Viral myocarditis
| Abatacept | 002 [28] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬307. Viral myocarditis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 308 | Viral protein interaction with cytokine and cytokine receptor 💬 18 genes, 31 drugs (DrugBank) and 68 diseases |
TNF [1] TNF 💬Viral protein interaction with cytokine and cytokine receptor
|
Adalimumab Adalimumab 💬Viral protein interaction with cytokine and cytokine receptor
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬308. Viral protein interaction with cytokine and cytokine receptor
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 309 | Virion - Adenovirus 💬 2 genes, 2 drugs (DrugBank) and 28 diseases |
CD80 [2] CD80, CD86 💬
|
Abatacept Abatacept 💬Virion - Adenovirus
| Abatacept | 002 [28] 2 , 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬309. Virion - Adenovirus
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 310 | Virion - Hepatitis viruses 💬 3 genes, 12 drugs (DrugBank) and 19 diseases |
EGFR [1] EGFR 💬Virion - Hepatitis viruses
|
Erlotinib hydrochloride Erlotinib hydrochloride 💬Virion - Hepatitis viruses
| Erlotinib | 094 [2] 94, 160 💬310. Virion - Hepatitis viruses
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 311 | Virion - Hepatitis viruses 💬 3 genes, 12 drugs (DrugBank) and 19 diseases |
EGFR [1] EGFR 💬Virion - Hepatitis viruses
|
Erlotinib Erlotinib 💬Virion - Hepatitis viruses
| Erlotinib | 094 [2] 94, 160 💬310. Virion - Hepatitis viruses
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 312 | Wnt signaling pathway 💬 10 genes, 12 drugs (DrugBank) and 60 diseases |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬Wnt signaling pathway
|
Pimecrolimus Pimecrolimus 💬Wnt signaling pathway
| Pimecrolimus | 160 [1] 160 💬312. Wnt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 313 | Yersinia infection 💬 25 genes, 43 drugs (DrugBank) and 78 diseases |
TNF [1] TNF 💬Yersinia infection
|
Adalimumab Adalimumab 💬Yersinia infection
| Adalimumab | 019 [22] 19, 37, 38, 40, 41, 46, 55, 56, 84, 90, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬313. Yersinia infection
|
Acute myeloid leukemia
18 genes, 37 drugs (DrugBank) and 71 diseases
Adherens junction
13 genes, 25 drugs (DrugBank) and 34 diseases
Adipocytokine signaling pathway
18 genes, 40 drugs (DrugBank) and 108 diseases
African trypanosomiasis
10 genes, 24 drugs (DrugBank) and 66 diseases
AGE-RAGE signaling pathway in diabetic complications
28 genes, 58 drugs (DrugBank) and 100 diseases
Alcoholic liver disease
43 genes, 56 drugs (DrugBank) and 98 diseases
Allograft rejection
31 genes, 25 drugs (DrugBank) and 63 diseases
Alzheimer disease
59 genes, 136 drugs (DrugBank) and 139 diseases
Amoebiasis
20 genes, 32 drugs (DrugBank) and 77 diseases
Amphetamine addiction
25 genes, 58 drugs (DrugBank) and 92 diseases
AMPK signaling pathway
16 genes, 58 drugs (DrugBank) and 100 diseases
Amyotrophic lateral sclerosis
39 genes, 58 drugs (DrugBank) and 116 diseases
Antigen processing and presentation
23 genes, 15 drugs (DrugBank) and 60 diseases
Apoptosis
18 genes, 32 drugs (DrugBank) and 68 diseases
Arachidonic acid metabolism
5 genes, 29 drugs (DrugBank) and 46 diseases
Asthma
21 genes, 24 drugs (DrugBank) and 61 diseases
Autoimmune thyroid disease
42 genes, 16 drugs (DrugBank) and 38 diseases
Axon guidance
22 genes, 26 drugs (DrugBank) and 73 diseases
B cell receptor signaling pathway
19 genes, 38 drugs (DrugBank) and 68 diseases
Bile secretion
13 genes, 36 drugs (DrugBank) and 66 diseases
Bladder cancer
11 genes, 26 drugs (DrugBank) and 33 diseases
Breast cancer
22 genes, 64 drugs (DrugBank) and 84 diseases
C-type lectin receptor signaling pathway
28 genes, 71 drugs (DrugBank) and 108 diseases
Cadherin signaling
41 genes, 70 drugs (DrugBank) and 81 diseases
Calcium signaling pathway
82 genes, 215 drugs (DrugBank) and 140 diseases
cAMP signaling pathway
67 genes, 191 drugs (DrugBank) and 133 diseases
Cell adhesion molecule (CAM) interaction
41 genes, 32 drugs (DrugBank) and 40 diseases
Cellular senescence
35 genes, 48 drugs (DrugBank) and 97 diseases
Central carbon metabolism in cancer
20 genes, 37 drugs (DrugBank) and 70 diseases
cGMP-PKG signaling pathway
48 genes, 132 drugs (DrugBank) and 123 diseases
Chagas disease
32 genes, 59 drugs (DrugBank) and 88 diseases
Chemical carcinogenesis - reactive oxygen species
24 genes, 37 drugs (DrugBank) and 53 diseases
Chemical carcinogenesis - receptor activation
41 genes, 140 drugs (DrugBank) and 133 diseases
Choline metabolism in cancer
11 genes, 29 drugs (DrugBank) and 64 diseases
Colorectal cancer
15 genes, 27 drugs (DrugBank) and 62 diseases
Coronavirus disease
56 genes, 115 drugs (DrugBank) and 109 diseases
Cushing syndrome
23 genes, 56 drugs (DrugBank) and 71 diseases
Cytokine-cytokine receptor interaction
90 genes, 141 drugs (DrugBank) and 104 diseases
Diabetic cardiomyopathy
25 genes, 48 drugs (DrugBank) and 80 diseases
Dilated cardiomyopathy
23 genes, 61 drugs (DrugBank) and 93 diseases
Dopaminergic synapse
33 genes, 105 drugs (DrugBank) and 105 diseases
Efferocytosis
30 genes, 78 drugs (DrugBank) and 97 diseases
Endocytosis
25 genes, 41 drugs (DrugBank) and 54 diseases
Endometrial cancer
10 genes, 19 drugs (DrugBank) and 28 diseases
Epithelial cell signaling in Helicobacter pylori infection
12 genes, 19 drugs (DrugBank) and 30 diseases
Epstein-Barr virus infection
67 genes, 97 drugs (DrugBank) and 83 diseases
ErbB signaling pathway
14 genes, 27 drugs (DrugBank) and 65 diseases
Estrogen signaling pathway
20 genes, 80 drugs (DrugBank) and 70 diseases
Fc epsilon RI signaling pathway
19 genes, 49 drugs (DrugBank) and 71 diseases
Fluid shear stress and atherosclerosis
33 genes, 60 drugs (DrugBank) and 100 diseases
Focal adhesion
31 genes, 52 drugs (DrugBank) and 54 diseases
FoxO signaling pathway
26 genes, 43 drugs (DrugBank) and 62 diseases
Gap junction
27 genes, 103 drugs (DrugBank) and 87 diseases
Gastric cancer
23 genes, 41 drugs (DrugBank) and 69 diseases
Glioma
15 genes, 34 drugs (DrugBank) and 67 diseases
Glucagon signaling pathway
15 genes, 26 drugs (DrugBank) and 85 diseases
Glutamatergic synapse
23 genes, 32 drugs (DrugBank) and 82 diseases
GnRH signaling pathway
16 genes, 40 drugs (DrugBank) and 47 diseases
Graft-versus-host disease
28 genes, 26 drugs (DrugBank) and 68 diseases
Hematopoietic cell lineage
47 genes, 97 drugs (DrugBank) and 101 diseases
Hepatitis B
44 genes, 70 drugs (DrugBank) and 92 diseases
Hepatitis C
37 genes, 75 drugs (DrugBank) and 92 diseases
Hepatocellular carcinoma
22 genes, 33 drugs (DrugBank) and 70 diseases
Herpes simplex virus 1 infection
71 genes, 85 drugs (DrugBank) and 110 diseases
HIF-1 signaling pathway
26 genes, 56 drugs (DrugBank) and 87 diseases
Human cytomegalovirus infection
65 genes, 121 drugs (DrugBank) and 136 diseases
Human immunodeficiency virus 1 infection
51 genes, 59 drugs (DrugBank) and 98 diseases
Human papillomavirus infection
52 genes, 114 drugs (DrugBank) and 121 diseases
Human T-cell leukemia virus 1 infection
61 genes, 80 drugs (DrugBank) and 105 diseases
Hypertrophic cardiomyopathy
26 genes, 57 drugs (DrugBank) and 97 diseases
IgSF CAM signaling
45 genes, 68 drugs (DrugBank) and 91 diseases
IL-17 signaling pathway
20 genes, 65 drugs (DrugBank) and 91 diseases
Inflammatory bowel disease
38 genes, 49 drugs (DrugBank) and 75 diseases
Influenza A
67 genes, 84 drugs (DrugBank) and 101 diseases
Insulin resistance
19 genes, 38 drugs (DrugBank) and 104 diseases
Integrin signaling
28 genes, 48 drugs (DrugBank) and 77 diseases
Intestinal immune network for IgA production
33 genes, 40 drugs (DrugBank) and 53 diseases
JAK-STAT signaling pathway
60 genes, 117 drugs (DrugBank) and 116 diseases
Kaposi sarcoma-associated herpesvirus infection
61 genes, 102 drugs (DrugBank) and 124 diseases
Legionellosis
10 genes, 24 drugs (DrugBank) and 68 diseases
Leishmaniasis
40 genes, 76 drugs (DrugBank) and 105 diseases
Lipid and atherosclerosis
52 genes, 73 drugs (DrugBank) and 107 diseases
Long-term potentiation
18 genes, 37 drugs (DrugBank) and 87 diseases
Malaria
17 genes, 31 drugs (DrugBank) and 69 diseases
MAPK signaling pathway
70 genes, 101 drugs (DrugBank) and 117 diseases
Measles
42 genes, 72 drugs (DrugBank) and 70 diseases
Melanoma
17 genes, 34 drugs (DrugBank) and 45 diseases
MicroRNAs in cancer
32 genes, 78 drugs (DrugBank) and 96 diseases
mTOR signaling pathway
15 genes, 33 drugs (DrugBank) and 99 diseases
Natural killer cell mediated cytotoxicity
45 genes, 49 drugs (DrugBank) and 91 diseases
Necroptosis
34 genes, 60 drugs (DrugBank) and 82 diseases
NF-kappa B signaling pathway
23 genes, 81 drugs (DrugBank) and 97 diseases
NOD-like receptor signaling pathway
33 genes, 57 drugs (DrugBank) and 79 diseases
Non-alcoholic fatty liver disease
24 genes, 54 drugs (DrugBank) and 100 diseases
Non-small cell lung cancer
21 genes, 39 drugs (DrugBank) and 57 diseases
Oocyte meiosis
14 genes, 39 drugs (DrugBank) and 73 diseases
Osteoclast differentiation
40 genes, 93 drugs (DrugBank) and 109 diseases
Ovarian steroidogenesis
7 genes, 40 drugs (DrugBank) and 53 diseases
Oxytocin signaling pathway
34 genes, 85 drugs (DrugBank) and 112 diseases
Pancreatic cancer
20 genes, 43 drugs (DrugBank) and 86 diseases
Parathyroid hormone synthesis, secretion and action
24 genes, 63 drugs (DrugBank) and 70 diseases
Pathogenic Escherichia coli infection
31 genes, 46 drugs (DrugBank) and 84 diseases
Pathways in cancer
116 genes, 235 drugs (DrugBank) and 150 diseases
Pathways of neurodegeneration - multiple diseases
64 genes, 143 drugs (DrugBank) and 141 diseases
PD-L1 expression and PD-1 checkpoint pathway in cancer
34 genes, 70 drugs (DrugBank) and 104 diseases
Pertussis
23 genes, 48 drugs (DrugBank) and 77 diseases
Phospholipase D signaling pathway
24 genes, 60 drugs (DrugBank) and 84 diseases
PI3K-Akt signaling pathway
86 genes, 147 drugs (DrugBank) and 129 diseases
PPAR signaling pathway
12 genes, 19 drugs (DrugBank) and 38 diseases
Prion disease
41 genes, 77 drugs (DrugBank) and 121 diseases
Prostate cancer
24 genes, 58 drugs (DrugBank) and 92 diseases
Proteoglycans in cancer
34 genes, 75 drugs (DrugBank) and 107 diseases
Rap1 signaling pathway
47 genes, 115 drugs (DrugBank) and 101 diseases
Ras signaling pathway
38 genes, 65 drugs (DrugBank) and 77 diseases
Regulation of actin cytoskeleton
37 genes, 82 drugs (DrugBank) and 79 diseases
Relaxin signaling pathway
23 genes, 34 drugs (DrugBank) and 53 diseases
Renin secretion
28 genes, 90 drugs (DrugBank) and 108 diseases
Rheumatoid arthritis
39 genes, 59 drugs (DrugBank) and 85 diseases
RIG-I-like receptor signaling pathway
24 genes, 20 drugs (DrugBank) and 61 diseases
Salmonella infection
32 genes, 48 drugs (DrugBank) and 78 diseases
Serotonergic synapse
40 genes, 130 drugs (DrugBank) and 89 diseases
Shigellosis
31 genes, 54 drugs (DrugBank) and 97 diseases
Small cell lung cancer
15 genes, 47 drugs (DrugBank) and 63 diseases
Sphingolipid signaling pathway
32 genes, 56 drugs (DrugBank) and 84 diseases
Systemic lupus erythematosus
30 genes, 49 drugs (DrugBank) and 90 diseases
T cell receptor signaling pathway
35 genes, 58 drugs (DrugBank) and 88 diseases
Terpenoid backbone biosynthesis
4 genes, 14 drugs (DrugBank) and 62 diseases
TGF-beta signaling pathway
15 genes, 29 drugs (DrugBank) and 70 diseases
Th1 and Th2 cell differentiation
45 genes, 57 drugs (DrugBank) and 83 diseases
Th17 cell differentiation
57 genes, 88 drugs (DrugBank) and 111 diseases
TNF signaling pathway
25 genes, 64 drugs (DrugBank) and 95 diseases
Toll-like receptor signaling pathway
41 genes, 68 drugs (DrugBank) and 84 diseases
Toxoplasmosis
41 genes, 53 drugs (DrugBank) and 78 diseases
Transcriptional misregulation in cancer
28 genes, 64 drugs (DrugBank) and 83 diseases
Tuberculosis
67 genes, 80 drugs (DrugBank) and 104 diseases
Type I diabetes mellitus
32 genes, 25 drugs (DrugBank) and 72 diseases
Type II diabetes mellitus
15 genes, 44 drugs (DrugBank) and 100 diseases
VEGF signaling pathway
22 genes, 58 drugs (DrugBank) and 94 diseases
Viral myocarditis
34 genes, 25 drugs (DrugBank) and 49 diseases
Viral protein interaction with cytokine and cytokine receptor
18 genes, 31 drugs (DrugBank) and 68 diseases
Virion - Adenovirus
2 genes, 2 drugs (DrugBank) and 28 diseases
Virion - Hepatitis viruses
3 genes, 12 drugs (DrugBank) and 19 diseases
Wnt signaling pathway
10 genes, 12 drugs (DrugBank) and 60 diseases
Yersinia infection
25 genes, 43 drugs (DrugBank) and 78 diseases
